Literature DB >> 3895174

Preventing pneumococcal disease in children: recommendations for using pneumococcal vaccine.

G S Giebink.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3895174     DOI: 10.1097/00006454-198507000-00001

Source DB:  PubMed          Journal:  Pediatr Infect Dis        ISSN: 0277-9730


× No keyword cloud information.
  8 in total

1.  Prevention of pneumococcal otitis media in chinchillas with human bacterial polysaccharide immune globulin.

Authors:  P A Shurin; G S Giebink; D L Wegman; D Ambrosino; J Rholl; M Overman; T Bauer; G R Siber
Journal:  J Clin Microbiol       Date:  1988-04       Impact factor: 5.948

2.  Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine.

Authors:  G Vidarsson; S T Sigurdardottir; T Gudnason; S Kjartansson; K G Kristinsson; G Ingolfsdottir; S Jonsson; H Valdimarsson; G Schiffman; R Schneerson; I Jonsdottir
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

3.  Distribution of serotypes of Streptococcus pneumoniae isolated from invasive infections over a 16-year period in the greater São Paulo area, Brazil.

Authors:  M C Brandileone; V S Vieira; R C Zanella; I M Landgraf; C E Melles; A Taunay; J C de Moraes; R Austrian
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

4.  Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.

Authors:  A Sabirov; S Kodama; T Hirano; M Suzuki; G Mogi
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

5.  Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections.

Authors:  H Jakobsen; E Saeland; S Gizurarson; D Schulz; I Jónsdóttir
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

6.  Prevention of Pneumococcal Meningitis.

Authors:  Tina Q. Tan
Journal:  Curr Infect Dis Rep       Date:  2002-08       Impact factor: 3.725

7.  Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections.

Authors:  H Jakobsen; D Schulz; M Pizza; R Rappuoli; I Jónsdóttir
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

8.  Intranasal immunization with pneumococcal conjugate vaccines with LT-K63, a nontoxic mutant of heat-Labile enterotoxin, as adjuvant rapidly induces protective immunity against lethal pneumococcal infections in neonatal mice.

Authors:  Håvard Jakobsen; Stefania Bjarnarson; Giuseppe Del Giudice; Monique Moreau; Claire-Anne Siegrist; Ingileif Jonsdottir
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.